Teva (TEVA) volatility flat into Berkshire Hathaway (BRK.A) disclosed a stake in the company
Tweet
Share
E-mail
Get Alerts TEVA Hot Sheet
Price: $32.20 +2.29%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: -3.6%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: -3.6%
Join SI Premium – FREE
Teva Pharma (NYSE: TEVA) February call option implied volatility is at 58, March is at 45; compared to its 52-week range of 24 to 75 into Berkshire Hathaway (BRK.A) disclosed a stake in the company.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Carnival Corp. (CCL) call put ratio 1 call to 1.4 puts into quarter results
- Bending Spoons valuation up to $19 Billion in U.S. IPO - Reuters
- Accenture (ACN) spreader of 22700 contracts of August 120 puts and 22200 contracts of August 130 calls as share price down 7.2%
Create E-mail Alert Related Categories
Option EPS Action, Options, Trader TalkRelated Entities
Warren Buffett, OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
